Walmart to compete with Walgreens, CVS in recruiting clinical trial
subjects
Send a link to a friend
[October 11, 2022]
By Arriana McLymore
(Reuters) - Walmart said on Tuesday it
would begin to help drug companies and research firms identify and
recruit individuals to fill their clinical trials, pitting it against
rivals Walgreens and CVS Health Group .
Walmart Healthcare Research Institute, the largest U.S. retailer's new
healthcare research service, will find participants for clinical trials,
and Walmart also host MyHealthJourney, a patient portal that helps
people find upcoming research trials and track their care.
Walmart's expansion into clinical trial recruitment could bring it new
streams of revenue from drug companies.
John Wigneswaran, Walmart's chief medical officer, said the retailer's
clinics and pharmacies will become a "funnel" for healthcare
organizations that want access to its diverse populations of customers
for possible trials and studies.
Patient-recruitment is difficult in clinical trials. Studies can be
delayed or terminated when organizations are not able to get enough
people to participate or when patients drop out of the trial.
Senior citizens, rural populations, women and people of color in the
U.S. are often left out of clinical research because they lack awareness
of trials and access to facilities.
Walmart is currently working with Laina Enterprises, a virtual clinical
trial management platform, the retailer said in a press release.
Rival Walgreens said in June it had launched clinical trial services to
increase diversity in test subjects. A company spokesperson said
Walgreens is in talks with "many leading pharmaceutical companies" to
help with patient recruitment, virtual or hybrid clinical trials and
diversity initiatives.
According to a database of U.S. clinical trials seen by Reuters,
Walgreens worked with the University of North Texas Health Science
Center starting in 2018 for a study on African American HIV patients.
[to top of second column]
|
A shopper leaves a Walmart store in
Bradford, Pennsylvania, U.S. July 20, 2020. REUTERS/Brendan McDermid/File
Photo
Walmart has previously said it wants
to focus more on its high-margin businesses including healthcare,
financial services and advertising.
"Walgreens is making a push to utilize their stores to reach their
more diverse population in their clinical trials, so it seems
feasible that that's something that Walmart may eventually want to
do as well," said Carri Chan, a professor at Columbia Business
School.
Walmart opened Walmart Health locations in Dallas, Georgia in 2019
and now has 24 locations including in Arkansas, Florida and
Illinois. In September, Walmart said it would partner with
UnitedHealth Group to provide preventative healthcare to elderly
populations and telehealth services for all age groups.
Meanwhile, CVS Health began offering clinical trials in 2021. CVS
Health Clinical Trial Services General Manager Tony Clapsis told
Reuters drug companies bear much of the costs, although some costs
might get picked up by Medicare, Medicaid or a commercial health
plan.
CVS has since conducted studies to track the emergence of COVID-19
variants while under contract to the U.S. Department of Health and
Human Services, according to its website.
It also is working on a flu study and collaborating with Pfizer to
recruit 600 participants for a study to determine the long-term
effects of COVID-19, according to patient recruitment listing seen
by Reuters.
(Reporting by Arriana McLymore; Editing by Lincoln Feast)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|